Core Viewpoint - The company, primarily engaged in the production and sales of cosmetic packaging containers, has faced significant challenges post-IPO, including declining revenues and profits due to the pandemic and underutilized production capacity [1][3]. Group 1: Financial Performance - The company's revenue and net profit showed strong growth before its IPO, with net profit nearly tripling from 2015 to 2019 [1]. - Post-IPO, the company has not recovered to pre-IPO revenue levels, with net profit experiencing three consecutive years of losses [1]. - The gross profit margin has declined significantly, dropping from over 35% before the IPO to less than half in the second year post-IPO [6]. Group 2: Production Capacity and Utilization - The company has a total production capacity of 11.4 million sets, including a new project that added 4.5 million sets, but production volumes have been significantly lower, with utilization rates of approximately 58.2% in 2021 and 45% in 2022 [3][4]. - In 2024, despite an increase in order volume, the production capacity utilization rate was only 71% [3]. Group 3: Expansion Projects and Related Transactions - The company has faced setbacks in its expansion plans, including the termination of a project aimed at increasing production capacity by 1.5 million sets [8]. - A new project to produce 6 million sets has been initiated, with an investment of 299 million yuan, but it has not yet resulted in operational machinery [8]. - The project involves a related party transaction, raising concerns about governance and potential implications for the ongoing investigation by the regulatory authority [8]. Group 4: Financial Anomalies - There has been a notable increase in short-term borrowings, which rose by 54.34% year-on-year, raising flags about potential financial irregularities [9]. - The company has explained the increase in borrowings as a response to business planning needs, although the related subsidiary has not engaged in substantial business activities [10][11].

Group 1 - The core issue is that Jinsheng New Materials is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to a significant drop in stock price [3] - On June 30, the stock opened sharply lower, nearing the daily limit down, with a decline of 19.11%, trading at 13.33 yuan per share and a total market capitalization of 2 billion yuan [1] - Jinsheng New Materials has reported consecutive losses over the past three years, with losses of 22.51 million yuan in 2022, 23.87 million yuan in 2023, and 22.65 million yuan in 2024, totaling over 69 million yuan [5] Group 2 - The company, established in 1998 and listed on the ChiNext board in July 2020, primarily engages in the research, production, and sales of plastic packaging containers for cosmetics [5] - The losses are attributed to a contraction in overseas markets and insufficient capacity utilization [5] - Investors affected by the company's alleged fraudulent activities may seek civil compensation under relevant laws, with the potential for claims dating back to the company's listing until June 27, 2025 [5]

Core Viewpoint - Zhejiang Jinsong New Materials Co., Ltd. is under formal investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact its stock performance and investor confidence [1][9]. Group 1: Company Overview - Jinsong New Materials, established in 1998, specializes in the research, production, and sales of plastic packaging containers for cosmetics, with over 1,000 product specifications [2]. - The company serves well-known clients such as Estée Lauder, Shanghai Jahwa, and Huaxi Biological [2]. - As of March 2025, the actual controllers of the company, Ruan Rongtao and Gao Lijun, hold a combined 35.11% of the company's shares [2]. Group 2: Financial Performance - Since its IPO in July 2020, the company has experienced a significant decline in profitability, with net profit dropping from 34.49 million yuan in 2020 to a loss of 22.51 million yuan in 2022 [3]. - The company has reported cumulative losses exceeding 69 million yuan over three consecutive years from 2021 to 2024 [3]. - The gross profit margin has decreased sharply from over 30% between 2016 and 2020 to 23.14% in 2021 and further down to 8.73% in 2022, indicating a nearly 80% decline in two years [6]. Group 3: Regulatory Environment - The company has committed to cooperating with the CSRC during the investigation and has stated that its normal business operations will not be significantly affected [2]. - The recent investigation highlights a "zero tolerance" approach by regulatory authorities towards information disclosure violations, as evidenced by penalties imposed on other companies [9]. - The new delisting rules pose additional risks for Jinsong New Materials, as administrative penalties for disclosure violations could lead to risk warnings, exacerbating the challenges faced by a company already experiencing continuous losses [11].

Group 1 - The core issue is that Jinsong New Material has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which adds uncertainty to its already challenging future prospects [1][3][5] - Jinsong New Material has reported net profit losses for three consecutive years, with a significant impact on its financial health due to the ongoing investigation [2][10] - The company has stated that it will cooperate with the CSRC during the investigation and that its normal production and operations will not be significantly affected [5] Group 2 - Financial performance has been declining, with a reported revenue of 243 million yuan in 2022, down 17.19% year-on-year, and a net loss of approximately 22.51 million yuan, a staggering drop of 312.62% [10] - In 2023, revenue slightly increased to 260 million yuan, a 7.04% growth, but net losses expanded to about 23.87 million yuan, a 6.07% increase in losses compared to the previous year [10][11] - For 2024, revenue grew significantly by 28.15% to 333 million yuan, yet the net loss remained substantial at approximately 22.65 million yuan, accumulating losses exceeding 69 million yuan over three years [10][11] - The company attributes the revenue growth to a recovery in the domestic and international cosmetics market, but rising management costs and asset impairment provisions have contributed to ongoing net losses [12]

Core Viewpoint - The upcoming week will see a total of 68 stocks facing a lock-up expiration, with a combined market value of 81.671 billion yuan [3]. Group 1: Company Announcements - Jinsong New Materials (300849) received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws [1]. - The company reported a revenue of 74.43 million yuan in Q1, a year-on-year increase of 10.97%, but incurred a net loss of 3.836 million yuan [1]. Group 2: Lock-up Expiration Details - Next week, 68 stocks will have a total lock-up expiration value of 81.671 billion yuan, calculated based on the latest closing prices [3]. - Zhong Wulun Drone will have 403 million shares released, with a lock-up value of 20.02 billion yuan [4]. - Dize Pharmaceutical-U will have 223 million shares released, with a lock-up value of 13.272 billion yuan [5]. Group 3: Performance of Stocks Facing Expiration - Among the 68 stocks, 18 reported losses in Q1, with Dize Pharmaceutical-U showing the largest loss of 193 million yuan [9]. - The average stock price of the stocks facing expiration has increased by 5.08% since June [8]. - Notable gainers include Jida Zhengyuan, Jinyinhai, and Aikesibo, each with over 30% price increases [8]. Group 4: Institutional Research - Ten stocks, including Zhong Keshuguang and Dema Technology, received research attention from over five institutions in June [9]. - Zhong Keshuguang was researched by 145 institutions, focusing on a strategic restructuring involving high-end processors [9]. - Dema Technology's global smart logistics business has seen significant breakthroughs in South America this year [9].

Group 1 - The State Council, led by Li Qiang, held a meeting to discuss the implementation of the national science and technology conference spirit to accelerate the construction of a strong technology nation [1] - The central bank aims to enhance support for technological innovation and boost consumption while exploring institutional arrangements to maintain capital market stability [2] - The Shanghai and Shenzhen stock exchanges announced an adjustment of the price fluctuation limit for risk-warning stocks on the main board from 5% to 10% [3] Group 2 - Xiaomi's official account reported that within 18 hours of opening sales, the Xiaomi YU7 has surpassed 240,000 units in locked orders [4] - The domestically produced GLP-1 weight loss drug, Masitide, has been approved for long-term weight control in adults with obesity or overweight [5] - Tianfeng Securities noted that the company's price-to-book ratio is higher than the industry median [6] - Aijian Group, which has seen three consecutive trading limit increases, stated that it has not engaged in any stablecoin-related business [6] - Times Wan Heng, which has seen two consecutive trading limit increases, focuses on the research, production, and sales of new energy batteries [6] - Jinsong New Materials is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6]

Core Viewpoint - Jinsheng New Materials is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact its operations and reputation in the market [2][4]. Company Overview - Jinsheng New Materials specializes in the research, production, and sales of plastic packaging containers for cosmetics, offering over 1,000 product specifications to well-known brands such as Estée Lauder, Oushiman, and Shanghai Jahwa [4]. - The company was officially listed on the Shenzhen Stock Exchange's Growth Enterprise Market on July 10, 2020 [4]. Financial Performance - The company's financial performance has deteriorated significantly since its second year post-listing, transitioning from profit to loss starting in 2022. Although there was a slight increase in net profit in 2024, the company remains in a net loss position [4]. - The cumulative losses over the past three years exceed 69 million yuan [5]. - As of March 31, 2025, the total operating revenue was approximately 744.34 million yuan, reflecting a year-on-year increase of 10.97% [5]. - The total operating costs were approximately 770.59 million yuan, leading to an operating loss of approximately 39.90 million yuan [5]. - The net profit for the same period was approximately -38.36 million yuan, marking a year-on-year decrease of 290.10% [5]. Market Position - As of June 27, 2025, Jinsheng New Materials' stock closed at 16.48 yuan per share, with a total market capitalization of 2.5 billion yuan [5].

Group 1 - The company, Jinsong New Materials (300849), received a notice from the China Securities Regulatory Commission (CSRC) on June 27, 2025, regarding a formal investigation due to suspected violations of information disclosure laws [1] - The CSRC has decided to initiate a case against the company, indicating serious regulatory scrutiny [1] - During the investigation period, the company will actively cooperate with the CSRC while maintaining normal operations across all business activities [1]

锦盛新材：因涉嫌信息披露违法违规 遭中国证监会立案调查 智通财经6月27日电，锦盛新材(300849.SZ)公告称，公司于2025年6月27日收到中国证监会下发的《立 案告知书》，因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。目前，公司各项生产经营活 动均正常开展，上述事项不会对公司的正常生产经营活动产生重大影响。 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：300849 证券简称：锦盛新材 公告编号：2025-022 浙江锦盛新材料股份有限公司 关于收到中国证券监督管理委员会立案告知书的公告 特此公告。 浙江锦盛新材料股份有限公司 董事会 2025 年 6 月 27 日 浙江锦盛新材料股份有限公司（以下简称"公司"）于 2025 年 6 月 27 日收 到中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告知书》 （编号：证监立案字 01120250021 号），因公司涉嫌信息披露违法违规，根据《中 华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会 决定对公司立案。 立案调查期间，公司将积极配合中国证监会的各项工作，严格按照相关规定 及监管要求履行信息披露义务。目前，公司各项生产经营活动均正常开展，上述 事项不会对公司的正常生产经营活动产生重大影响。 公司指定的信息披露媒体为《证券时报》《中国证券报》《上海证券报》和 巨潮资讯网（www.cninfo.com.cn），公司所有信息均以在上述指定媒体披露的公 告为准。敬请广大投 ...